TD Cowen Maintains Buy on Amgen, Raises Price Target to $452

Benzinga Newsdesk www.benzinga.com Positive 81.3%

Neg 0% Neu 0% Pos 81.3%

TD Cowen analyst Yaron Werber maintains Amgen (NASDAQ:AMGN) with a Buy and raises the price target from $420 to $452.

Comments

No comments yet. Be the first!